1. Home
  2. TNET vs IDYA Comparison

TNET vs IDYA Comparison

Compare TNET & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriNet Group Inc.

TNET

TriNet Group Inc.

HOLD

Current Price

$37.83

Market Cap

1.7B

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$34.46

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNET
IDYA
Founded
1988
2015
Country
United States
United States
Employees
2700
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.9B
IPO Year
2000
2019

Fundamental Metrics

Financial Performance
Metric
TNET
IDYA
Price
$37.83
$34.46
Analyst Decision
Hold
Strong Buy
Analyst Count
5
16
Target Price
$65.80
$51.21
AVG Volume (30 Days)
556.3K
707.7K
Earning Date
05-15-2026
05-19-2026
Dividend Yield
2.96%
N/A
EPS Growth
N/A
61.90
EPS
3.20
N/A
Revenue
$5,010,000,000.00
$218,710,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.30
$213.03
P/E Ratio
$11.91
N/A
Revenue Growth
N/A
3024.43
52 Week Low
$33.67
$13.45
52 Week High
$88.56
$39.28

Technical Indicators

Market Signals
Indicator
TNET
IDYA
Relative Strength Index (RSI) 39.97 54.97
Support Level $33.67 $32.85
Resistance Level $39.10 $36.38
Average True Range (ATR) 1.74 1.34
MACD 0.81 0.19
Stochastic Oscillator 70.31 73.93

Price Performance

Historical Comparison
TNET
IDYA

About TNET TriNet Group Inc.

Trinet Group Inc provides human resources solutions for small and medium-sized businesses through technology-enabled services. Its offerings include human capital expertise, employee benefits such as health insurance and retirement plans, payroll and payroll tax administration, risk mitigation, and compliance consulting. The company provides its services through professional employer organization (PEO) services delivered via a co-employment model, as well as administrative services organization (ASO) offerings. The majority of the company's revenue is derived from the insurance-related billings and administrative fees collected from PEO clients.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: